Hercules Capital

Palo Alto, USA
PE / DebtGrowthEst. US$10BWeb Research 2026

Investment Thesis

Hercules Capital is the largest non-bank venture debt lender globally, providing senior secured loans of $5M-$200M+ to high-growth, venture-backed companies in technology and life sciences. The fund delivers flexible, less-dilutive credit solutions to complement equity capital, enabling companies to extend runway, achieve milestones, and reach liquidity events with minimal equity dilution.

Focus Areas

Investment Stage
PE / DebtGrowth

Investment Signals

Check SizeC$6.5M to C$260M
GeographyNorth America
RoleBoth
Revenue Stagetraction required
Business ModelsB2B, SaaS, deep-tech

Sample Portfolio Companies

Marathon Health
Maze Therapeutics
MoonLake Immunotherapeutics
Armis
Fin
Oak Street Health
23andMe
4D Molecular Therapeutics
908 Devices
Acacia Pharma
Acceleron Pharma
AcelRx Pharmaceuticals

AUM & Sources

Est. US$10B
Assets under management (estimated)
Sources
No public sources found.
Raising from Canadian VCs?Get AI-matched to your top investors in seconds.
Find My Investors →

Similar Funds

See incorrect information?

Help us keep this directory accurate and up to date.